ASHLAND Pathways has learned its Certified Community Behavioral Health Clinic services have been accredited by the Commission ...
The FDA has accepted a New Drug Application (NDA) for Celcuity’s gedatolisib in hormone receptor positive (HR+), human ...
AI is transforming oncology by improving early detection, diagnosis, and treatment personalization through advanced data ...
New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia ...
The FDA has accepted an investigational new drug application from a global biotechnology company for its investigational, ...
Gedatolisib's NDA for advanced breast cancer treatment has been accepted by the FDA, with a priority review and a PDUFA date set for July 17, 2026. The drug is intended for HR+/HER2–, PIK3CA wild-type ...
A study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene ...
When it comes to children born with rare diseases, early diagnosis can make the difference between life and death. Since many ...
A new Cedars Sinai Physician Associated Study used the processes and care of Daybreak to evaluate a dentist-led, ...
4d
Understanding Alcohol-Related Facial Puffiness: New WhiteSands Treatment Center Resource Published
WhiteSands Alcohol & Drug Rehab Tampa has published a new educational resource exploring the physiological effects of alcohol ...
News-Medical.Net on MSN
Atypical mutation offers clues to personalized pancreatic cancer treatment
A new study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene ...
Health and Me on MSN
Scientists find possible breakthrough in bowel and liver cancer treatment
Scientists identify a protein linked to bowel and liver cancers that could lead to safer, targeted treatments as cases rise, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback